World Class Algorithms
Our autonomous AI research expands the reach of dermatological care beyond the exam room, from skin cancer to inflammatory disease. We are currently recruiting pilot locations and research groups interested in skin diagnostics and management.
* 3DermSpot is for Investigational Use Only
Latest News
3Derm Announces Two FDA Breakthrough Device Designations for Autonomous Skin Cancer AI
3DermSpot* is an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma.
3DermSpot is being developed in collaboration with primary care physicians and dermatologists across the country.
Our Focus
We’re committed to using technology to increase access for all patients by focusing on high-impact disease areas and solutions
Melanoma
Melanoma is the most lethal form of skin cancer. If not caught early, there is high risk of it spreading from the skin to other tissues and parts of the body.
Basal Cell Carcinoma
Basal cell carcinoma is the most common form of skin cancer. BCC are slow growing and are highly curable when caught and treated early.
Squamous Cell Carcinoma
Squamous cell carcinoma is a slow spreading cancer. When caught and treated early, SCC is highly curable.
Psoriasis
Psoriasis is a chronic inflammatory skin condition. It can be managed through a variety of treatments, from topical steroids to biologics.
Atopic Dermatitis
Atopic dermatitis, commonly referred to as eczema, is a chronic, itchy skin condition. It is typically treated by identifying triggers and/or moisturizing.
Autonomous AI
Our research prioritizes safety, efficacy, and equity.
-
Clear decision making
-
Representative training data
-
Standardized imaging
-
Incorporation of clinical standards of care
No Automation Without Representation
We stand for technology that works for every skin tone.
